The Lord Tarassenko | |
---|---|
Member of the House of Lords Lord Temporal | |
Assumed office 10 June 2024 Life peerage | |
President of Reuben College,Oxford | |
Assumed office 7 May 2019 | |
Preceded by | Office established |
Personal details | |
Born | Lionel Tarassenko 17 April 1957 Paris,France |
Nationality | British |
Political party | Crossbench |
Spouses | Ann Craven (m. 1978;div. 2001)Anne Le Grice (m. 2001) |
Children | 3 children, 3 step-children |
Alma mater | Keble College, Oxford |
Awards |
|
Scientific career | |
Fields | Biomedical Engineering, Signal Processing, Machine Learning, Digital Health |
Institutions | University of Oxford |
Lionel Tarassenko, Baron Tarassenko, CBE , FREng , FMedSci , FIET (born 17 April 1957), is a French-born British engineer, academic and life peer. A leading expert in the application of signal processing and machine learning to healthcare, he has been the president of Reuben College, Oxford, since 2019.
Tarassenko was previously Head of Department of Engineering Science (Dean of Engineering) at the University of Oxford, succeeded by Ronald A. Roy. [5] Towards the end of his time as dean, the department rose to first place in the Times Higher Education World University Rankings. [6]
In 1988, he was appointed as the first Tutorial Fellow in Engineering at St Hugh's College, Oxford and was a member of the college for over nine years. [7] Tarassenko was elected Professor of Electrical Engineering at the University of Oxford in 1997 [8] and was a Professorial Fellow of St John's College, Oxford, from 1997 to 2019. [9] In 2019 he was invited by the Vice-Chancellor Louise Richardson to oversee the development of Reuben College, the University's 39th college. [5] [10] He is also a Pro-Vice Chancellor [11] and the Chair of the Management Committee of the Maison Française d’Oxford. [12]
Tarassenko has authored more than 280 journal papers, 200 conference papers, 3 books, and more than 30 granted patents. [13] He has supervised 65 doctoral students. He has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012. [14] He was the R&D Director and Chair of the Strategic Advisory Board of Sensyne Health, an AIM-listed company from 2018 to 2022. [15] He is a director of the University’s wholly owned Technology Transfer company, Oxford University Innovation. [16] He was the editor-in-chief of the 2018 Topol Review of NHS Technology and its impact on the workforce. [17]
Tarassenko was the driving force behind the creation of the Institute of Biomedical Engineering (IBME) at the University of Oxford, which he directed from its opening in 2008 to 2012. He established an £8m Centre of Excellence in Medical Engineering within the IBME, [18] and led the Technology & Digital Health theme in the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre from its inception in 2007 until 2022. [19] Under his leadership, the IBME grew from 110 to 220 academic researchers and it was awarded a Queen’s Anniversary Prize for Higher Education in 2015 for “new collaborations between engineering and medicine delivering benefit to patients”. [20]
Lionel Tarassenko was born in Paris on 17 April 1957 to Sergei and Rachel Tarassenko. [21] His mother was French and his father, a nuclear physicist, was Ukrainian-Latvian. Tarassenko moved to England at the age of 13, gaining British citizenship in 1981. He gained a Bachelor of Arts (BA) degree in engineering science in 1978 at Keble College, Oxford, and obtained a DPhil in medical electronics in 1985, also at Keble College, for his work on the early identification of brain haemorrhages in pre-term infants. [22]
Together with Professor Alan Murray of University of Edinburgh, Tarassenko is the inventor of the pulse-stream technique for analogue implementation of massively parallel neural networks. [23] He gradually moved away from designing neural network hardware to developing new machine learning algorithms and applying them to problems as diverse as the automated re-heating of food and drinks in a microwave oven (implemented in the Sharp LogiCook oven) and the analysis of sleep disorders. This body of work was recognised in 1996 by the award of the IEE Mather Premium for innovation using neural networks. [1]
Tarassenko then went on to develop methods for learning how to characterise normality in safety-critical systems. With his research team, he designed the QUICK system, which was at the core of Rolls-Royce’s engine health monitoring strategy in the 1990s and the early 2000s. [24] [25] As a result, he and his Rolls-Royce collaborators were awarded the Chairman’s Team Award for Technical Innovation in 2001 and the Sir Henry Royce High Value Patent Award in 2008.
When he became the first Director of the Oxford Institute of Biomedical Engineering in 2008, Tarassenko focused his research on patient monitoring, both in and out of hospital. His work has had a major impact on the identification of deterioration in acute care and on the management of long-term conditions. He has been a pioneer in developing early warning systems for acutely ill patients. The machine-learning system (Visensia) which he designed for patient monitoring in critical care was the first such system to gain FDA approval (in 2008). [26]
In the last decade Tarassenko has led the engineering development of several digital health products including: (a) GDm-Health, a digital therapeutic for the management of gestational diabetes; [27] (b) SEND, a system for monitoring in-hospital patient vital signs and identifying deterioration early; [28] [29] (c) EDGE-COPD, a digital therapeutic for the self-monitoring and self-management of chronic obstructive pulmonary disease; and (d) Support-HF, a system for heart failure management in the community.
Tarassenko has been a founder director of four University spin-out companies, the latest being Oxehealth in September 2012. [30]
In May 2024, the House of Lords Appointments Commission recommended Tarassenko for appointment as a non-party-political life peer. [31] He was created Baron Tarassenko, of Headington in the City of Oxford, on 10 June 2024, [32] and was introduced to the House of Lords on 29 July as a crossbencher. [33] [34]
Tarassenko was elected to a Fellowship of the Institute of Electrical Engineers in 1996, when he was also awarded the IEE Mather Premium for his work on neural networks, to a Fellowship of the Royal Academy of Engineering in 2000, [1] [35] and to a Fellowship of the Academy of Medical Sciences in 2013. He received a British Computer Society Medal in 1996 for his work on neural network analysis of sleep disorders. His research on jet engine health monitoring was awarded the Rolls-Royce Chairman's Award for Technical Innovation in 2001 and the Sir Henry Royce High Value Patent Award in 2008. His work on mobile phones for healthcare was awarded the E-health 2005 Innovation Award for “best device to empower patients”. He received the 2006 Silver Medal of the Royal Academy of Engineering for his contribution to British engineering leading to market exploitation and he won the Institute of Engineering & Technology IT Award, also in 2006. In 2010, he gave the prestigious Vodafone lecture on mobile health at the Royal Academy of Engineering and the Centenary Lecture on Biomedical Engineering at the Indian Institute of Science in Bangalore. He received the 2015 Martin Black Prize from the Institute of Physics for the best paper in Physiological Measurement [3]
He was appointed a Commander of the Order of the British Empire (CBE) in the 2012 New Year Honours for services to engineering and a 'Chevalier dans l'Ordre national du Mérite' by the French state in 2021.
Tarassenko married Lady Ann Mary Elizabeth Craven, daughter of William Craven, 6th Earl of Craven, in 1978. They had two sons and a daughter, and divorced in 2001. [21] [36] [37] In the same year, Tarassenko married Anne Elizabeth Le Grice ( née Moss), with whom he has two stepsons and a stepdaughter. [21]
Tarassenko is a lay canon of Christ Church Cathedral, Oxford. [38]
Biomedical engineering (BME) or medical engineering is the application of engineering principles and design concepts to medicine and biology for healthcare applications. BME is also traditionally logical sciences to advance health care treatment, including diagnosis, monitoring, and therapy. Also included under the scope of a biomedical engineer is the management of current medical equipment in hospitals while adhering to relevant industry standards. This involves procurement, routine testing, preventive maintenance, and making equipment recommendations, a role also known as a Biomedical Equipment Technician (BMET) or as a clinical engineer.
The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.
Renato Marcos Endrizzi Sabbatini is a retired professor at the Department of Biomedical Engineering and at the State University of Campinas Institute of Biology. He received a B.Sc. in Biomedical Sciences from Medical School of the University of São Paulo and a doctorate in behavioral neuroscience in 1977, followed by postdoctoral work at the Max Planck Institute of Psychiatry's Primate Behavior Department. He founded the Center for Biomedical Informatics, and helped create the Brazilian Society for Health Informatics.
Ara Warkes Darzi, Baron Darzi of Denham is an Armenian-British surgeon, academic, and politician.
John Radcliffe Hospital is a large tertiary teaching hospital in Oxford, England. It forms part of Oxford University Hospitals NHS Foundation Trust and is named after John Radcliffe, an 18th-century physician and Oxford University graduate, who endowed the Radcliffe Infirmary, the main hospital for Oxford from 1770 until 2007.
The Department of Engineering Science is the engineering department of the University of Oxford. It is part of the university's Mathematical, Physical and Life Sciences Division. The department was ranked third best institute in the UK for engineering in the 2021 Research Excellence Framework.
Bin He is a Chinese American biomedical engineering scientist. He is the Trustee Professor of the Department of Biomedical Engineering, professor by courtesy in the Department of Electrical and Computer Engineering, and Professor of Neuroscience Institute, and was the head of the department of Biomedical Engineering at Carnegie Mellon University. Prior, he was Distinguished McKnight University Professor of Biomedical Engineering and Medtronic-Bakken Endowed Chair for Engineering in Medicine at the University of Minnesota. He previously served as the director of the Institute for Engineering in Medicine and the Center for Neuroengineering at the University of Minnesota. He was the Editor in Chief of the IEEE Transactions on Biomedical Engineering and serves as the editor in chief of IEEE Reviews in Biomedical Engineering. He was the president of the IEEE Engineering in Medicine & Biology Society (EMBS) from 2009 to 2010 and chair of International Academy of Medical and Biological Engineering from 2018 to 2021.
The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.
The UCLH Biomedical Research Centre is a biomedical research centre based in London. It is a partnership between University College London Hospitals NHS Foundation Trust (UCLH), University College London (UCL) the National Institute for Health and Care Research (NIHR) and UCLPartners. It was one of the original five Comprehensive Biomedical Research Centres established by the NIHR in April 2007.
Andrew Jonathan Carr, FMedSci is a British surgeon and has been the sixth Nuffield Professor of Orthopaedics and head of the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences at the University of Oxford since 2001.
Sir John Michael Brady is an emeritus professor of oncological imaging at the University of Oxford. He has been a Fellow of Keble College, Oxford, since 1985 and was elected a foreign associate member of the French Academy of Sciences in 2015. He was formerly BP Professor of Information Engineering at Oxford from 1985 to 2010 and a senior research scientist in the MIT Computer Science and Artificial Intelligence Laboratory (CSAIL) in Cambridge, Massachusetts, from 1980 to 1985.
Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.
Andrew Tym Hattersley CBE FRS is a Professor of Molecular Medicine at the University of Exeter and is known for his research in monogenic diabetes. He was elected a Fellow of the Royal Society in 2010. He is also an Emeritus Senior Investigator at the National Institute for Health and Care Research (NIHR).
The Henry Royce Institute is the UK’s national institute for advanced materials research and innovation.
Julia Alison Noble is a British engineer. She has been Technikos Professor of Biomedical Engineering at the University of Oxford and a fellow of St Hilda's College since 2011, and Associate Head of the Mathematical, Physical and Life Sciences Division at the university. As of 2017, she is the chief technology officer of Intelligent Ultrasound Limited, an Oxford spin-off in medical imaging that she cofounded. She was director of the Oxford Institute of Biomedical Engineering (IBME) from 2012 to 2016. In 2023 she became the Foreign Secretary of The Royal Society.
Eleanor Phoebe Jane Stride is a Professor of Biomaterials at St Catherine's College, Oxford. Stride engineers drug delivery systems using carefully designed microbubbles and studies how they can be used in diagnostics.
Monica Lakhanpaul FRCPCH is a British Indian consultant paediatrician at Whittington Health NHS Trust, and Professor of Integrated Community Child Health at University College London (UCL). She was Deputy Theme Lead for Collaborations in Leadership in Applied Health Research and Care – North Thames, and is currently Adjunct Professor at Public Health Foundation India, UCL Global Strategic Academic Advisor (India), National Patient and Public Engagement Lead for the NIHR GOSH Biomedical Research Centre and NIHR National Specialty Lead for Children.
Konstantina "Nantia" Nikita is a Greek electrical and computer engineer and a professor at the School of Electrical and Computer Engineering at the National Technical University of Athens (NTUA), Greece. She is director of the Mobile Radiocommunications Lab and founder and director of the Biomedical Simulations and Imaging Lab, NTUA. Since 2015, she has been an Irene McCulloch Distinguished Adjunct Professor of Biomedical Engineering and Medicine at Keck School of Medicine and Viterbi School of Engineering, University of Southern California.
Gari David Clifford is a British-American physicist, biomedical engineer, academic, and researcher. He is the Chair of Emory's Department of Biomedical Informatics and a Professor of Biomedical Engineering and Biomedical Informatics at Emory University and Georgia Institute of Technology.
Mohamad Sawan is a Canadian-Lebanese electrical engineer, academic and researcher. He is a Chair Professor at Westlake University, China, and an Emeritus Professor of Electrical Engineering at Polytechnique Montréal, Canada.